Inventor · disambiguated record
Joe G.N. Garcia
Also filed as: GARCIA JOE G N
16 granted patents·21 pending applications·23 citations·filing 2004–2023
89Inventor score
Top patents by PatentIndex Score
37 records- 0187US10961582B2Biomarkers for assessing idiopathic pulmonary fibrosisUNIV CHICAGO·Filed 2018·Granted Mar 30, 2021·3 cites·12 claims
- 0286US11466099B2Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodiesAQUALUNG THERAPEUTICS CORP·Filed 2021·Granted Oct 11, 2022·3 cites·19 claims
- 0382US8518962B2Use of opioid antagonistsMOSS JONATHAN·Filed 2010·Granted Aug 27, 2013·6 cites·5 claims
- 0480US10036069B2Biomarkers for assessing idiopathic pulmonary fibrosisUNIV CHICAGO·Filed 2012·Granted Jul 31, 2018·3 cites·8 claims
- 0579US9409983B2Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseasesGARCIA JOE G N·Filed 2010·Granted Aug 9, 2016·5 cites·11 claims
- 0677US2024085422A1Biomarkers and methods of use for radiation-induced lung injuryUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 0774US8524731B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationMOSS JONATHAN·Filed 2006·Granted Sep 3, 2013·2 cites·10 claims
- 0870US11733242B2Biomarkers and methods of use for radiation-induced lung injuryUNIV ARIZONA·Filed 2019·Granted Aug 22, 2023·0 cites·20 claims
- 0970US9662390B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationMOSS JONATHAN·Filed 2006·Granted May 30, 2017·1 cites·4 claims
- 1067US9662325B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2014·Granted May 30, 2017·0 cites·9 claims
- 1167US2021145825A1Use of opioid antagonistsUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 1266US2023220113A1Anti-human nicotinamide phosphoribosyltransferase (nampt) antibodiesAQUALUNG THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1366US2022235417A1Biomarkers for assessing idiopathic pulmonary fibrosisUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 1464US2018008594A1Use of opioid antagonistsUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 1561US9717725B2Use of opioid antagonistsUNIV CHICAGO·Filed 2013·Granted Aug 1, 2017·0 cites·9 claims
- 1660US11142586B2Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodiesAQUALUNG THERAPEUTICS·Filed 2020·Granted Oct 12, 2021·0 cites·17 claims
- 1760US10975167B2Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferaseUNIV ARIZONA·Filed 2018·Granted Apr 13, 2021·0 cites·22 claims
- 1858US2023265516A1Single nucleotide polymorphisms and treatment of inflammatory conditionsUNIV OF ARIZONA ARIZONA BOARD OF REGENTS·Filed 2021·Application pending·0 cites
- 1955US9675602B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2013·Granted Jun 13, 2017·0 cites·10 claims
- 2055US2009197922A1Compositions and methods for treating pulmonary hypertensionUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 2154US2017252336A1Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 2254US2022290246A1Single nucleotide polymorphisms and uses thereofUNIV ARIZONA·Filed 2020·Application pending·0 cites
- 2353US2005004029A1Methods and compositions for treating vascular leak using hepatocyte growth factorFiled 2004·Application pending·0 cites
- 2453US2014142133A1Modulation of cell barrier dysfunctionUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 2552US10300036B2Compositions and methods for treating and preventing lung injuryUNIV ARIZONA·Filed 2016·Granted May 28, 2019·0 cites·7 claims
- 2652US2015133333A1Compositions and methods for detecting complicated sarcoidosisUNIV ILLINOIS·Filed 2014·Application pending·0 cites
- 2750US10993936B2Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferaseUNIV ARIZONA·Filed 2018·Granted May 4, 2021·0 cites·23 claims
- 2850US2008194611A1Modulation of Cell Barrier DysfunctionALVERDY JOHN C·Filed 2006·Application pending·0 cites
- 2948US2010249064A1Methods and compositions for treating diseases and conditions involving higher molecular weight hyaluronanUNIV CHICAGO·Filed 2008·Application pending·0 cites
- 3047US2012316190A1Modulation of Cell Barrier DysfunctionALVERDY JOHN C·Filed 2012·Application pending·0 cites
- 3146US10633710B2Methods for characterizing cancerUNIV ARIZONA·Filed 2015·Granted Apr 28, 2020·0 cites·4 claims
- 3245US2017258909A1Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 3343US2009186949A1Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like CompoundsUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 3438US2014323545A1Nitrated sphingosine 1-phosphate 3 receptor as a predictor of acute lung injury-associated mortalityGARCIA JOE G N·Filed 2012·Application pending·0 cites
- 3535US2013079309A1Method Of Treating Acute Lung Injury Using Sphingosine 1 Phosphate Analogs Or Sphingosine 1 Phosphate Receptor AgonistsGARCIA JOE G N·Filed 2011·Application pending·0 cites
- 3633US2006194765A1Methods and compositions using oxidized phospholipidsGARCIA JOE G N·Filed 2005·Application pending·0 cites
- 3729US2012028921A1Methods and compositions using oxidized phospholipidsGARCIA JOE G N·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joe G.N. Garcia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →